CHEBI:180695 - fasudil hydrochloride hydrate

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name fasudil hydrochloride hydrate
ChEBI ID CHEBI:180695
Definition A hydrate that is the hemihydrate form of fasudil hydrochloride. It is a drug indicated for the prevention of cerebral vasospasm and ensuing cerebral ischemia following surgery for subarachnoid hemorrhage.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C14H17N3O2S.C14H17N3O2S.H2O.ClH.ClH
Net Charge 0
Average Mass 673.670
Monoisotopic Mass 672.17222
InChI InChI=1S/2C14H17N3O2S.2ClH.H2O/c2*18-20(19,17-9-2-6-15-8-10-17)14-4-1-3-12-11-16-7-5-13(12)14;;;/h2*1,3-5,7,11,15H,2,6,8-10H2;2*1H;1H2
InChIKey AACOJGPCMIDLEY-UHFFFAOYSA-N
SMILES O.Cl.Cl.O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2.O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
Roles Classification
Biological Role(s): calcium channel blocker
One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools.
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of non-specific serine/threonine protein kinase (EC 2.7.11.1), a kinase enzyme involved in phosphorylation of hydroxy group of serine or threonine.
Application(s): antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
nootropic agent
Any compound that improves mental functions such as cognition, memory, intelligence, motivation, attention, and concentration.
vasodilator agent
A drug used to cause dilation of the blood vessels.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing fasudil hydrochloride hydrate (CHEBI:180695) has part fasudil hydrochloride (CHEBI:31593)
fasudil hydrochloride hydrate (CHEBI:180695) has role antihypertensive agent (CHEBI:35674)
fasudil hydrochloride hydrate (CHEBI:180695) has role calcium channel blocker (CHEBI:38215)
fasudil hydrochloride hydrate (CHEBI:180695) has role EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor (CHEBI:50925)
fasudil hydrochloride hydrate (CHEBI:180695) has role neuroprotective agent (CHEBI:63726)
fasudil hydrochloride hydrate (CHEBI:180695) has role nootropic agent (CHEBI:66980)
fasudil hydrochloride hydrate (CHEBI:180695) has role vasodilator agent (CHEBI:35620)
fasudil hydrochloride hydrate (CHEBI:180695) is a hydrate (CHEBI:35505)
IUPAC Name
5-(1,4-diazepane-1-sulfonyl)isoquinoline—hydrogen chloride—water (2/2/1)
Synonyms Sources
5-(1,4-diazepan-1-ylsulfonyl)isoquinoline hydrochloride hydrate (2:2:1) IUPAC
5-(hexahydro-1H-1,4-diazepine-1-ylsulfonyl)isoquinoline hydrochloride hemihydrate ChemIDplus
fasudil HCl hemihydrate ChEBI
fasudil HCl semihydrate DrugCentral
fasudil hydrochloride hemihydrate ChemIDplus
Brand Name Source
Eril ChemIDplus
Registry Number Type Source
186694-02-0 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
15998434 PubMed citation Europe PMC
19052484 PubMed citation Europe PMC
19817300 PubMed citation Europe PMC
21433064 PubMed citation Europe PMC
21457293 PubMed citation Europe PMC
21743486 PubMed citation Europe PMC
24438608 PubMed citation Europe PMC
25120610 PubMed citation Europe PMC
28535907 PubMed citation Europe PMC
Last Modified
08 October 2021